131 related articles for article (PubMed ID: 7708571)
1. [Use of ifosfamide in multidrug therapy of small cell lung carcinoma].
Pawlicki M; Krzemieniecki K
Pol Tyg Lek; 1994 May 2-9; 49(18-19):425-6. PubMed ID: 7708571
[TBL] [Abstract][Full Text] [Related]
2. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M
Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478
[TBL] [Abstract][Full Text] [Related]
3. Ifosfamide, doxorubicin, vincristine, and etoposide in small cell lung cancer.
Elisson LO; Ekberg L
Semin Oncol; 1995 Feb; 22(1 Suppl 2):15-7. PubMed ID: 7846536
[TBL] [Abstract][Full Text] [Related]
4. A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer.
Takahashi M; Yoshizawa H; Tanaka H; Tanaka J; Kagamu H; Ito K; Shimbo T; Chou D; Wakabayashi M; Suzuki E; Sakai K; Arakawa M; Gejyo F
Bone Marrow Transplant; 2000 Jan; 25(1):5-11. PubMed ID: 10654007
[TBL] [Abstract][Full Text] [Related]
5. [Pilot study of sequential chemotherapy and radiation therapy using of liniac and fast neutron for limited small cell lung cancer].
Takiguchi Y; Nagao K; Miyamoto T; Takamura M; Yasukawa T; Kuriyama T
Gan To Kagaku Ryoho; 1995 Jun; 22(7):957-9. PubMed ID: 7794004
[No Abstract] [Full Text] [Related]
6. Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT study.
Perey L; Rosti G; Lange A; Pampallona S; Bosquée L; Pasini F; Humblet Y; Hamdan O; Cetto GL; Marangolo M; Leyvraz S
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S40-3. PubMed ID: 8899170
[No Abstract] [Full Text] [Related]
7. [Ifosfamide and adriamycin after induction with cisplatin and etoposide (VP-16) in pulmonary microcytoma. Preliminary results].
Antilli A; Cruciani AR; Nunziati F; Orazi D; Portalone L; Signora M; Salvati F
G Ital Chemioter; 1985; 32(1):71-2. PubMed ID: 3007254
[No Abstract] [Full Text] [Related]
8. [Evaluation of the second line of treatment of patients with small cell carcinoma of the lung].
Roszkowski K; Janic G; Jassem J; Karnicka-Młodkowska H; Szczepek B; Traczyk K; Zych J; Rowińska-Zakrzewska E
Pneumonol Pol; 1989 Apr; 57(4):240-8. PubMed ID: 2560830
[TBL] [Abstract][Full Text] [Related]
9. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
[TBL] [Abstract][Full Text] [Related]
10. Hoosier Oncology Group studies in extensive and recurrent small cell lung cancer.
Einhorn LH; Loehrer PJ
Semin Oncol; 1995 Feb; 22(1 Suppl 2):28-31. PubMed ID: 7846539
[TBL] [Abstract][Full Text] [Related]
11. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
Ettinger DS
Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of adriamycin, etoposide plus ifosfamide on small cell lung cancer--a retrospective analysis of 69 cases treated in Centre Hospitalo-Universitaire de Bordeaux].
Su Y
Ai Zheng; 2006 Dec; 25(12):1569-72. PubMed ID: 17166389
[TBL] [Abstract][Full Text] [Related]
13. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
14. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
[TBL] [Abstract][Full Text] [Related]
15. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
[TBL] [Abstract][Full Text] [Related]
16. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
17. [Small-cell lung cancer].
Perevodchikova NI
Vopr Onkol; 1989; 35(2):151-4. PubMed ID: 2538957
[No Abstract] [Full Text] [Related]
18. Induction chemotherapy with ifosfamide, etoposide, and anthracycline for small cell lung cancer: experience of the European Lung Cancer Working Party.
Sculier JP; Bureau G; Giner V; Thiriaux J; Michel J; Berchier MC; Van Cutsem O; Küstner U; Kroll F; Mommen P
Semin Oncol; 1995 Feb; 22(1 Suppl 2):18-22. PubMed ID: 7846537
[TBL] [Abstract][Full Text] [Related]
19. [Peripheral blood stem cell harvest in patients with limited stage small-cell lung cancer].
Katakami N; Takakura S; Fujii H; Nishimura T; Umeda B
Gan To Kagaku Ryoho; 2000 Jun; 27(6):865-71. PubMed ID: 10897213
[TBL] [Abstract][Full Text] [Related]
20. [CAV-PVP chemotherapy and sequential thoracic irradiation (TI) for patients with limited (LD) small cell lung cancer (SCLC)].
Ueoka H; Ohnoshi T; Hiraki S; Kamei H; Tabata M; Shibayama T; Miyatake K; Gemba K; Hiyama J; Kimura I
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():218-24. PubMed ID: 8007469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
